Skip to Main Content
Table 3.

Changes in tumor on CT and FDG-PET

After stopping gefitinib or erlotinibAfter restarting gefitinib or erlotinib3 wks after adding everolimus
Median change in tumor diameter +9% −1% −8% 
Mean change in tumor diameter +9% 1% −9% 
Range in change in tumor diameter −13% to +29% −14% to +23% −34% to +15% 
Median change in tumor volume +50% −1% −11% 
Mean change in tumor volume +61% −4% −10% 
Range in change in tumor volume −4% to +260% −27% to 15% −40% to +26% 
Median change in SUVmax +18% −4% −18% 
Mean change in SUVmax +23% −11% −11% 
Range in change in SUVmax −17% to +87% −45% to +62% −39% to +82% 
After stopping gefitinib or erlotinibAfter restarting gefitinib or erlotinib3 wks after adding everolimus
Median change in tumor diameter +9% −1% −8% 
Mean change in tumor diameter +9% 1% −9% 
Range in change in tumor diameter −13% to +29% −14% to +23% −34% to +15% 
Median change in tumor volume +50% −1% −11% 
Mean change in tumor volume +61% −4% −10% 
Range in change in tumor volume −4% to +260% −27% to 15% −40% to +26% 
Median change in SUVmax +18% −4% −18% 
Mean change in SUVmax +23% −11% −11% 
Range in change in SUVmax −17% to +87% −45% to +62% −39% to +82% 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept